Skip to content

Tango Therapeutics vs TransCode Therapeutics, Inc.

Tango Therapeutics logo

Tango Therapeutics

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medicines

182 employees · est. 2017 · Boston, United States

VS
TransCode Therapeutics, Inc. logo

TransCode Therapeutics, Inc.

Delivering a cancer-free future

11 employees · est. 2016 · Newton, United States

TransCode Therapeutics, Inc. is the older company (2017 vs 2016); Tango Therapeutics is the larger of the two.

Side-by-Side Comparison

Tango Therapeutics TransCode Therapeutics, Inc.
Founded
2017 2016 older
Headquarters
Boston, United States Newton, United States
Employees
182 larger 11
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Post-IPO Equity Post-IPO Equity
Total Funding
$351.00M $28.05M
Funding Rounds
4 10
Services
Medicine Development, Genetically Targeted Therapies, Cancer Treatment Research, Clinical Trials, Drug Pipeline Expansion, Biotechnology Innovations Not tracked yet
Target Customers
Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Researchers, Biopharma Investors Not tracked yet
Taxonomy
Clinical-stagePrecision MedicineCancer TreatmentTumor Suppressor TargetingSynthetic LethalityCRISPR-based Discovery +8 Cancer TherapeuticsTargeted TherapiesBiomarker TargetingRNA-based TherapiesGene TherapyOncology Research +9
Website
tangotx.com transcodetherapeutics.com
Tango Therapeutics logo

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company, established in 2017, focused on developing precision medicines to target cancer by exploiting tumor suppressor loss. Its mission is encapsulated in the slogan: "Targeting tumor suppressor loss to unmask vulnerabilities for the next genera...

TransCode Therapeutics, Inc. logo

About TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc. is a biotechnology startup founded in 2016, with a mission to deliver a cancer-free future for all cancer patients. The company focuses on the intelligent design and efficient delivery of targeted therapeutics, particularly TTX-MC138, which targets microRNA-10b, consider...

Also comparing in this category

Comparing more than these two?

Get Tango Therapeutics, TransCode Therapeutics, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Tango Therapeutics compare?

A PDF of Tango Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Tango Therapeutics was founded in 2017, based in Boston, United States, with 182 employees. Tango Therapeutics is a clinical-stage biotechnology company, established in 2017, focused on developing precision medicines to target cancer by exploiting tumor suppressor loss. Its mission is encaps. TransCode Therapeutics, Inc. was founded in 2016, based in Newton, United States, with 11 employees. TransCode Therapeutics, Inc. is a biotechnology startup founded in 2016, with a mission to deliver a cancer-free future for all cancer patients. The company focuses on the intelligent design and effic.
Tango Therapeutics has raised $351.00M and TransCode Therapeutics, Inc. $28.05M. Latest stage: Tango Therapeutics Post-IPO Equity, TransCode Therapeutics, Inc. Post-IPO Equity.
Both work in Biotechnology, Health Care and Health and Wellness and list precision medicine and targeted therapies among their focus areas.

Compare Tango Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Tango Therapeutics on 15 Jun 2026, and TransCode Therapeutics, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout